F, G., H, H., U, S., N, E., V, N., J, T., . . . R, H. (2025). The impact of oral anticoagulants on idiopathic pulmonary fibrosis risk and prognosis: A population study. The European respiratory journal, 66(3), . https://doi.org/10.1183/13993003.00432-2025
Chicago Style (17th ed.) CitationF, Gonnelli, et al. "The Impact of Oral Anticoagulants on Idiopathic Pulmonary Fibrosis Risk and Prognosis: A Population Study." The European Respiratory Journal 66, no. 3 (2025). https://doi.org/10.1183/13993003.00432-2025.
MLA (9th ed.) CitationF, Gonnelli, et al. "The Impact of Oral Anticoagulants on Idiopathic Pulmonary Fibrosis Risk and Prognosis: A Population Study." The European Respiratory Journal, vol. 66, no. 3, 2025, https://doi.org/10.1183/13993003.00432-2025.